Antibody Production Government Contracts

AI Summary

The Defense Health Agency intends to procure contact activation pathway function blocking antibody AB023 from Oregon Health & Science University through a sole source contract. Interested parties may submit capability information by July 9, 2026, to determine the potential for competitive procurement.

AI Summary

The Defense Health Agency is seeking information on potential qualified offerors for the contact activation pathway function blocking antibody AB023. This RFI aims to gather market research and assess capabilities for providing this specialized antibody, which targets specific blood clotting factors while preserving na…

AI Summary

The Department of Health and Human Services is seeking proposals for the Rapid Antigen Production for Immunoassay Diagnostics (RAPID) project. This initiative aims to develop rapid antibody generation platforms for timely production of diagnostic reagents. A virtual Proposer’s Conference will be held on April 27, 2026,…

AI Summary

The USDA Agricultural Research Service is soliciting quotes for monoclonal antibody production related to US H5 HPAI. This opportunity is a Request for Quote (RFQ) and requires compliance with the Statement of Work. Quotes must be submitted electronically by November 12, 2025, and will be evaluated based on technical a…

AI Summary

The Department of Health and Human Services is seeking innovative solutions to enhance antibody manufacturing capabilities. This initiative aims to improve scalability, cost-efficiency, and adaptability in production processes using advanced technologies. Interested parties should focus on improvements applicable acros…

AI Summary

The Department of Defense, specifically the Defense Health Agency (DHA), has issued a solicitation for a contract focused on hybridoma development studies and antibody production. This opportunity is intended for severable, non-personal services and is aimed at supporting the Division of Virology at the U.S. Army Medic…